Trial Profile
A Phase II Open-Label, Randomized, Multi-Centre Comparative Study Of Bevacizumab-Based Therapy In Paediatric Patients With Newly Diagnosed Supratentorial, Infratentorial Cerebellar, Or Peduncular High-Grade Glioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide
- Indications Anaplastic astrocytoma; Astrocytoma; Ependymoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- Acronyms HERBY
- Sponsors Roche
- 13 Mar 2020 This trial was completed in Netherlands (end date: 2020-01-29), according to European Clinical Trials Database.
- 12 Mar 2020 Status changed from active, no longer recruiting to completed.
- 04 Mar 2020 This trial has been completed in France, according to European Clinical Trials Database record.